Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2382 Views
-
Last post by frodo
-
- 0 Replies
- 12270 Views
-
Last post by NHE
-
- 0 Replies
- 209 Views
-
Last post by tzootsi
-
- 2 Replies
- 1741 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1317 Views
-
Last post by NHE
-
- 2 Replies
- 1995 Views
-
Last post by frodo
-
- 0 Replies
- 12792 Views
-
Last post by NHE
-
- 0 Replies
- 2706 Views
-
Last post by frodo
-
- 0 Replies
- 2902 Views
-
Last post by NHE